Literature DB >> 8772726

Regulation of proliferation and differentiation of human fetal pancreatic islet cells by extracellular matrix, hepatocyte growth factor, and cell-cell contact.

G M Beattie1, J S Rubin, M I Mally, T Otonkoski, A Hayek.   

Abstract

Ex vivo expansion of human fetal pancreatic endocrine cells is important for biological studies and as a potential tissue source for transplantation in insulin-deficient states. In tissue culture experiments involving the use of hepatocyte growth factor/scatter factor and selected extracellular matrices, we obtained a 30-fold increase in cell number of human fetal pancreatic epithelial cells. This proliferation in monolayer culture was associated with marked downregulation of insulin and glucagon gene expression. However, gene expression increased when the cells were combined into three-dimensional aggregates, suggesting that cell-cell contact mediated mechanisms regulate the transcription of islet-specific genes, a process enhanced by nicotinamide (NIC). After transplantation into nude mice, either as cell suspensions or aggregates, only the cell aggregates treated with NIC developed into mature functional islet-like structures. These are the first experiments to describe the interactions of specific matrices and growth factors in the ex vivo expansion of human fetal pancreatic cells, and they also show the importance of cell aggregates in the context of cellular and molecular events that might positively influence islet cell transplantation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8772726     DOI: 10.2337/diab.45.9.1223

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  37 in total

1.  Nestin-positive progenitor cells isolated from human fetal pancreas have phenotypic markers identical to mesenchymal stem cells.

Authors:  Ling Zhang; Tian-Pei Hong; Jiang Hu; Yi-Nan Liu; Yong-Hua Wu; Ling-Song Li
Journal:  World J Gastroenterol       Date:  2005-05-21       Impact factor: 5.742

2.  Increased vulnerability of newly forming beta cells to cytokine-induced cell death.

Authors:  J J Meier; R A Ritzel; K Maedler; T Gurlo; P C Butler
Journal:  Diabetologia       Date:  2005-12-02       Impact factor: 10.122

3.  Surrogate beta cells.

Authors:  S Ferber; H Heimberg; M Brownlee; C Colton
Journal:  Diabetologia       Date:  1997-10       Impact factor: 10.122

Review 4.  The impact of IUGR on pancreatic islet development and β-cell function.

Authors:  Brit H Boehmer; Sean W Limesand; Paul J Rozance
Journal:  J Endocrinol       Date:  2017-08-14       Impact factor: 4.286

Review 5.  In vitro reconstitution of pancreatic islets.

Authors:  Nobuhiko Kojima
Journal:  Organogenesis       Date:  2014-03-03       Impact factor: 2.500

Review 6.  Extracellular Matrix Scaffold Technology for Bioartificial Pancreas Engineering: State of the Art and Future Challenges.

Authors:  Marcus Salvatori; Ravi Katari; Timil Patel; Andrea Peloso; Jon Mugweru; Kofi Owusu; Giuseppe Orlando
Journal:  J Diabetes Sci Technol       Date:  2014-01-01

7.  Regulated expansion of human pancreatic beta-cells.

Authors:  Eszter Pais; Jean Park; Tamas Alexy; Vahagn Nikolian; Shundi Ge; Kit Shaw; Shantha Senadheera; Cinnamon L Hardee; Dianne Skelton; Roger Hollis; Gay M Crooks; Donald B Kohn
Journal:  Mol Ther       Date:  2010-04-13       Impact factor: 11.454

8.  In Depth Quantification of Extracellular Matrix Proteins from Human Pancreas.

Authors:  Fengfei Ma; Daniel M Tremmel; Zihui Li; Christopher B Lietz; Sara Dutton Sackett; Jon S Odorico; Lingjun Li
Journal:  J Proteome Res       Date:  2019-07-01       Impact factor: 4.466

Review 9.  Alternatives to unmodified human islets for transplantation.

Authors:  Alberto Hayek; Gillian M Beattie
Journal:  Curr Diab Rep       Date:  2002-08       Impact factor: 4.810

10.  Maturation and function of human embryonic stem cell-derived pancreatic progenitors in macroencapsulation devices following transplant into mice.

Authors:  Jennifer E Bruin; Alireza Rezania; Jean Xu; Kavitha Narayan; Jessica K Fox; John J O'Neil; Timothy J Kieffer
Journal:  Diabetologia       Date:  2013-06-16       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.